Aeglea BioTherapeutics (AGLE) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.31
-0.27
-0.22
-0.18

Details

Expected EPS
-0.18
Actual EPS
-0.2
Surprise EPS
-0.02
Surprise Percent
+11.11%

Description

Aeglea BioTherapeutics (AGLE) has reported earnings of -0.2 per share for Q1 2023.

0 Comments

Share your thoughts